Display options
Share it on

JIMD Rep. 2018;40:91-95. doi: 10.1007/8904_2017_68. Epub 2017 Nov 10.

Mitochondrial Trifunctional Protein Deficiency: Severe Cardiomyopathy and Cardiac Transplantation.

JIMD reports

C Bursle, R Weintraub, C Ward, R Justo, J Cardinal, D Coman

Affiliations

  1. Department of Metabolic Medicine, The Lady Cilento Children's Hospital, Brisbane, QLD, Australia.
  2. School of Medicine, University of Queensland, Brisbane, QLD, Australia.
  3. Department of Cardiology, The Royal Children's Hospital, Melbourne, VIC, Australia.
  4. School of Medicine, University of Melbourne, Melbourne, VIC, Australia.
  5. Department of Cardiology, The Lady Cilento Children's Hospital, Brisbane, QLD, Australia.
  6. Cardinal Bioresearch, Brisbane, QLD, Australia.
  7. Department of Metabolic Medicine, The Lady Cilento Children's Hospital, Brisbane, QLD, Australia. [email protected].
  8. School of Medicine, University of Queensland, Brisbane, QLD, Australia. [email protected].
  9. Department of Paediatrics, The Wesley Hospital, Brisbane, QLD, Australia. [email protected].
  10. School of Medicine, Griffith University, Gold Coast, QLD, Australia. [email protected].

PMID: 29124685 PMCID: PMC6122028 DOI: 10.1007/8904_2017_68

Abstract

We describe mitochondrial trifunctional protein deficiency (MTPD) in two male siblings who presented with severe cardiomyopathy in infancy. The first sibling presented in severe cardiac failure at 6 months of age and succumbed soon after. The second sibling came to attention after newborn screening identified a possible fatty acid oxidation defect. Dietary therapy and carnitine supplementation commenced in the neonatal period. Despite this the second child required cardiac transplantation at 3 years of age after a sudden and rapid decline in cardiac function. The outcome has been excellent, with no apparent extra-cardiac manifestations of a fatty acid oxidation disorder at the age of 7. Pathogenic HADHA mutations were subsequently identified via genome wide exome sequencing. This is the first reported case of MTPD to undergo cardiac transplantation. We suggest that cardiac transplantation could be considered in the treatment of cardiomyopathy in MTPD.

Keywords: Cardiomyopathy; Fatty acid oxidation; Mitochondrial trifunctional protein; Transplant

References

  1. PLoS One. 2012;7(11):e48628 - PubMed
  2. Mol Genet Metab. 2011 Aug;103(4):341-8 - PubMed
  3. J Pediatr. 2003 Jun;142(6):684-9 - PubMed
  4. Biosci Rep. 2016 Feb 02;36(2):null - PubMed
  5. Intern Med J. 2014 Dec;44(12a):1223-31 - PubMed
  6. Mol Genet Metab. 2015 Sep-Oct;116(1-2):53-60 - PubMed
  7. Curr Opin Cardiol. 2017 Jan;32(1):69-77 - PubMed
  8. Mol Genet Metab. 2011 Dec;104(4):556-9 - PubMed
  9. J Inherit Metab Dis. 2010 Oct;33(5):469-77 - PubMed
  10. Mol Genet Metab. 2008 Aug;94(4):428-30 - PubMed
  11. Orphanet J Rare Dis. 2015 Feb 22;10:21 - PubMed
  12. Hum Mutat. 2015 Feb;36(2):232-9 - PubMed
  13. Anal Biochem. 1990 May 1;186(2):280-4 - PubMed
  14. Semin Fetal Neonatal Med. 2011 Aug;16(4):216-21 - PubMed
  15. Pediatrics. 2002 Jan;109(1):99-104 - PubMed
  16. Mol Genet Metab. 2005 Jun;85(2):108-14 - PubMed
  17. J Biol Chem. 1992 Jan 15;267(2):1034-41 - PubMed
  18. Genomics. 1996 Oct 1;37(1):141-3 - PubMed
  19. Clin Exp Pharmacol Physiol. 2002 Apr;29(4):339-45 - PubMed
  20. Cardiol Young. 2016 Jun;26(5):851-9 - PubMed
  21. J Inherit Metab Dis. 2014 Jan;37(1):137-9 - PubMed
  22. Pathol Int. 2003 Nov;53(11):775-9 - PubMed
  23. Hum Mol Genet. 2014 Mar 1;23(5):1311-9 - PubMed
  24. J Bioenerg Biomembr. 2013 Feb;45(1-2):47-57 - PubMed
  25. J Biol Chem. 2010 Sep 24;285(39):29834-41 - PubMed
  26. Neuromuscul Disord. 1996 Oct;6(5):327-37 - PubMed
  27. Eur J Pediatr. 2000 Apr;159(4):243-6 - PubMed
  28. J Pediatr. 2007 Apr;150(4):407-11 - PubMed
  29. Biochem Biophys Res Commun. 1994 Mar 15;199(2):818-25 - PubMed
  30. Eur J Pediatr. 2015 Dec;174(12):1689-92 - PubMed
  31. J Biol Chem. 1984 Dec 25;259(24):15040-5 - PubMed

Publication Types